Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 998 | 918 | 998 | 1088 | 1325 | 1845 |
Fund Return | -0.23% | -8.25% | -0.23% | 2.84% | 5.8% | 6.31% |
Place in category | 812 | 920 | 812 | 99 | 202 | 173 |
% in Category | 87 | 95 | 87 | 15 | 41 | 68 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Seligson Co Global Top 25 Brands Fu | 738.96M | 13.54 | 4.65 | 11.45 | ||
Seligson & Co Global Top 25 Brands | 738.96M | 13.53 | 4.65 | 11.42 | ||
Seligson & Co North American A | 575.14M | 33.97 | 12.91 | 14.13 | ||
Seligson North American B | 575.14M | 33.96 | 12.91 | 14.12 | ||
FI4000283031 | 385.74M | 38.07 | 14.69 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Danske Invest MediLife T | 527.89M | 6.85 | 0.97 | 8.90 | ||
Danske Invest MediLife K | 90.85M | 6.85 | 0.95 | 8.90 | ||
Seligson Co Global Top 25 Pharma A | 250.83M | -0.23 | 2.84 | 6.29 | ||
LahiTapiola Hyvinvointi A | 124.72M | 1.33 | -2.07 | 6.97 | ||
LahiTapiola Hyvinvointi B | 124.72M | 1.33 | -2.06 | 6.97 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novartis | CH0012005267 | 6.79 | 93.80 | +0.39% | |
Roche Holding Participation | CH0012032048 | 6.78 | 285.20 | +1.57% | |
AstraZeneca | GB0009895292 | 6.73 | 11,314.0 | +0.73% | |
J&J | US4781601046 | 6.63 | 152.87 | +1.14% | |
Merck&Co | US58933Y1055 | 6.54 | 98.95 | +0.68% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Neutral | Neutral |
Technical Indicators | Strong Buy | Strong Sell | Strong Sell |
Summary | Strong Buy | Sell | Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review